This brand name is authorized in Germany, Estonia, Lithuania
The drug LISKANTIN contains one active pharmaceutical ingredient (API):
|
1
Primidone
UNII 13AFD7670Q - PRIMIDONE
|
|
Primidone is an anticonvulsant. Although the precise mode of action of primidone is unknown, in common with other anticonvulsants, effects on the neuronal membrane particularly with respect to alteration of ionic fluxes are likely to play a fundamental role. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AA03 | Primidone | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 01358519, 01358525, 04897168, 04897174 |
| Country: EE | Ravimiamet | Identifier(s): 1009336, 1077027 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004588 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
